References
- Rankin J. London loses EU agencies to Paris and Amsterdam in Brexit relocation. The Guardian newspaper. [cited 2017 Nov 20]. Available from: https://www.theguardian.com/politics/2017/nov/20/london-loses-european-medicines-agency-amsterdam-brexit-relocation.
- Johnston I. Brexit: people will die because of plans to set up UK-only drug regulator, cancer specialist warns. The Independent newspaper. [cited 2017 Feb 10]. Available from: http://www.independent.co.uk/life-style/health-and-families/health-news/brexit-latest-news-people-die-uk-only-drug-regulator-ema-leave-cancer-specialist-paul-workman-a7573851.html.
- Savage M. Brexit to swallow £70m meant for developing cancer drugs, says GSK. The Guardian newspaper. [cited 2018 Jan 6]. Available from: https://amp.theguardian.com/politics/2018/jan/06/brexit-will-divert-70m-from-our-cancer-drug-making-capacity-glaxosmithkline?CMP=Share_iOSApp_Other&__twitter_impression=true
- Smith MT. Mechanisms of troglitazone hepatotoxicity. Chem Res Toxicol. 2003;16:679–687.
- US Food and Drug Administration (History). [Cited 2018 Apr 12]. Available from: https://www.fda.gov/AboutFDA/WhatWeDo/History/.
- US Department of Health & Human Services (FDA Budget Overview). [Cited 2018 Apr 12]. Available from: www.hhs.gov/about/budget/budget-in-brief/fda/index.html
- Food and Drug Administration Distribution of Full-Time Equivalent (FTE) Employment. [Cited 2018 Apr 12]. Available from: www.fda.gov/downloads/AboutFDA/ReportsManualsForms/Reports/BudgetReports/UCM301553.pdf.
- European Medicines Agency (‘About Us’). [Cited 2018 Apr 12]. Available from: www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/document_listing/document_listing_000426.jsp&mid=.
- Garattini S. The European Medicines Agency is still too close to industry. BMJ. 2016;353:i2412.
- Pace J, Ghinea N, Kerridge I, et al. Accelerated access to medicines: an ethical analysis. Ther Innov Regul Sci. 2016;51(2):157–163.
- Pace J, Ghinea N, Kerridge I, et al. Demands for access to new therapies: are there alternatives to accelerated access? Bmj. 2017;359:j4494.
- European Medicines Agency (Partners and Networks). [Cited 2018 Apr 12]. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/partners_and_networks/document_listing/document_listing_000262.jsp&mid=WC0b01ac058009b148.
- Golding BT. The impact of Brexit on British science: also Sprach Zunderland. Future Med Chem. 2017;9:271–273.
- Withers I. Pharma firms encounter overseas talent shortages amid Brexit vote. The Daily Telegraph newspaper. [cited 2018 Jan 7]. Available from: http://www.telegraph.co.uk/business/2018/01/07/pharma-firms-encounter-overseas-talent-shortages-amid-brexit/.
- BMA. Press release. [cited 2017 Nov 14]. Available from: www.bma.org.uk/news/media-centre/press-releases/2017/november/almost-a-fifth-of-eu-doctors-have-made-plans-to-leave-uk-following-brexit-vote).
- Golec de Zavala A, Guerra R, Simão C. The relationship between the Brexit vote and individual predictors of prejudice: collective narcissism, right wing authoritarianism, social dominance orientation. Front Psychol. 2017;8:1–14. Article 2023.
- Fahy N, Hervey T, Greer S, et al. How will Brexit affect health and health services in the UK? Evaluating three possible scenarios. Lancet. 2017;390:2110–2118.
- Curto A, van der Vooren K, Garattini L. Market approval for drugs in the EU: time to change direction? Eur J Health Econ. 2017;18:933–936.
- Innovative Medicines Initiative. [Cited 2018 Apr 12]. Available from: www.imi.europa/eu.
- Klein EY, Van Boeckel TP, Martinez EM, et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Nat Acad Sci USA. 2018;115:E3463–E3470.